Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
APPLICATION OF SESQUITERPENE LACTONE COMPOUND IN PREPARATION OF DRUGS FOR ALLEVIATING RADIOTHERAPY-INDUCED INJURIES
Document Type and Number:
WIPO Patent Application WO/2022/083632
Kind Code:
A1
Abstract:
An application of a Sesquiterpene lactone compound, and a stereoisomer, isotopic marker, solvate and polymorph thereof, or a pharmaceutically acceptable salt thereof in the preparation of drugs for alleviating radiotherapy-induced injuries. The Sesquiterpene lactone compound is applied to assist radiotherapy, can effectively alleviate the radiotherapy-induced injuries, achieves a protection effect on normal cell tissues of a human body, and has a broad medicinal value.

Inventors:
CHEN YUE (CN)
CAI DONGPO (CN)
BAO SHIQI (CN)
ZHANG XUEMEI (CN)
CHEN JING (CN)
GONG JIANMIAO (CN)
GUO JIANSHUANG (CN)
LI JING (CN)
Application Number:
PCT/CN2021/124940
Publication Date:
April 28, 2022
Filing Date:
October 20, 2021
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
ACCENDATECH (CN)
UNIV NANKAI (CN)
International Classes:
A61K31/365; A61P35/04; A61P39/00
Domestic Patent References:
WO2010059245A22010-05-27
Foreign References:
US20190314324A12019-10-17
CN202011149717A2020-10-23
CN202111084087A2021-09-14
Other References:
TONG LUQING, LI JIABO, LI QIUYING, WANG XUYA, MEDIKONDA RAVI, ZHAO TIANNA, LI TAO, MA HAIWEN, YI LI, LIU PEIDONG, XIE YANG, CHOI J: "ACT001 reduces the expression of PD-L1 by inhibiting the phosphorylation of STAT3 in glioblastoma", THERANOSTICS, IVYSPRING INTERNATIONAL PUBLISHER, AU, vol. 10, no. 13, 1 January 2020 (2020-01-01), AU , pages 5943 - 5956, XP055923377, ISSN: 1838-7640, DOI: 10.7150/thno.41498
MOREL KATHERINE L., ORMSBY REBECCA J., BEZAK EVA, SWEENEY CHRISTOPHER J., SYKES PAMELA J.: "Parthenolide Selectively Sensitizes Prostate Tumor Tissue to Radiotherapy while Protecting Healthy Tissues In Vivo,", RADIATION RESEARCH, vol. 187, no. 5, 3 March 2017 (2017-03-03), US , pages 501 - 512, XP009535901, ISSN: 0033-7587, DOI: 10.1667/RR14710.1
ZHOU GUIJUAN, XU YAN, HE BING, MA RUNDONG, WANG YILIN, CHANG YUNQIAN, XIE YANGZHI, WU LIN, HUANG JIANGHUA, XIAO ZIJIAN: "Ionizing radiation modulates vascular endothelial growth factor expression through STAT3 signaling pathway in rat neonatal primary astrocyte cultures", BRAIN AND BEHAVIOR, vol. 10, no. 4, 1 April 2020 (2020-04-01), pages 1529 - 12, XP055923382, ISSN: 2162-3279, DOI: 10.1002/brb3.1529
XI XIAONAN, LIU NING, WANG QIANQIAN, CHU YAHUI, YIN ZHENG, DING YAHUI, LU YAXIN: "ACT001, a novel PAI-1 inhibitor, exerts synergistic effects in combination with cisplatin by inhibiting PI3K/AKT pathway in glioma", CELL DEATH & DISEASE, vol. 10, no. 10, 1 October 2019 (2019-10-01), pages 757, XP055923385, DOI: 10.1038/s41419-019-1986-2
DERASKA PETER V., O’LEARY COLIN, REAVIS HUNTER D., LABE SHELBY, DINH TRU-KHANG, LAZARO JEAN-BERNARD, SWEENEY CHRISTOPHER, D’ANDREA: "NF-κB inhibition by dimethylaminoparthenolide radiosensitizes non-small-cell lung carcinoma by blocking DNA double-strand break repair", CELL DEATH DISCOVERY, vol. 4, no. 1, 1 December 2018 (2018-12-01), pages 10, XP055923386, DOI: 10.1038/s41420-017-0008-3
MOREL KATHERINE L., ORMSBY REBECCA J., KLEBE SONJA, SWEENEY CHRISTOPHER J., SYKES PAMELA J.: "DMAPT is an effective radioprotector from long-term radiation-induced damage to normal mouse tissues in vivo,", RADIATION RESEARCH, vol. 192, no. 2, 16 May 2019 (2019-05-16), US , pages 231 - 139, XP009535900, ISSN: 0033-7587, DOI: 10.1667/RR15404.1
LICKLITER JASON D., JENNENS ROSS, LEMECH CHARLOTTE ROSE, KICHENADASSE GANESSAN, CAI DONGPO, SU STEVEN YUNG-CHANG: "Phase 1 dose-escalation study of ACT001 in patients with recurrent glioblastoma and other advanced solid tumors,", JOURNAL OF CLINICAL ONCOLOGY, vol. 39, no. 15 S, 28 May 2021 (2021-05-28), US , pages 2037 - 2037, XP009535899, ISSN: 0732-183X, DOI: 10.1200/JCO.2021.39.15_suppl.2037
Attorney, Agent or Firm:
BEIJING ORIGINTELLIGENCE IP LAW FIRM (CN)
Download PDF: